SCHEMBL3972849

SCHEMBL3972849

COc1ccc(/C=N\NC(=O)CSc2cc(C)c3cccc(C)c3n2)cc1OC

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.69
▸ LMNA P02545 2/20 0.69
▸ POLB P06746 7/20 0.65
▸ GAA P10253 4/20 0.61
▸ TRPM5 Q9NZQ8 4/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ ABL1 P00519 2/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ RIN1 Q13671 2/20 0.56
▸ HTT P42858 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ NSD2 O96028 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ APEX1 P27695 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ BLM P54132 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972853 1.00 MAPT (0.69) MAPTLMNAPOLBGAATRPM5
SCHEMBL10153052 1.00 MAPT (0.69) MAPTLMNAPOLBGAATRPM5
SCHEMBL2977982 0.78 ALDH1A1 (0.76) ALDH1A1
SCHEMBL2977980 0.78 ALDH1A1 (0.76) ALDH1A1
Hydrochloric Acid SCHEMBL944142 0.77 — —
Hydrochloric Acid SCHEMBL944140 0.77 — —
SCHEMBL1223531 0.76 POLB (1.00) MAPTPOLBGAATRPM5ALDH1A1
SCHEMBL1223533 0.76 POLB (1.00) MAPTPOLBGAATRPM5ALDH1A1
SCHEMBL12881226 0.76 POLB (1.00) MAPTPOLBGAATRPM5ALDH1A1
SCHEMBL1225432 0.75 TRPM5 (1.00) MAPTLMNAPOLBGAATRPM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951215-A4 HYDRAZONE DERIVATIVES AND USES THEREOF REDPOINT BIO CORP (US) 2009-07-29 — — EP claimed
EP-1951215-A2 HYDRAZONE DERIVATIVES AND USES THEREOF Redpoint Bio Corporation (US) 2008-08-06 — — EP claimed
US-20070207093-A1 Hydrazone derivatives and uses thereof LINQUAGEN CORP. 2007-09-06 — — US claimed
WO-2007056159-A2 HYDRAZONE DERIVATIVES AND USES THEREOF REDPOINT BIO CORPORATION (US) 2007-05-18 — — WO claimed
EP-1951215-A4 HYDRAZONE DERIVATIVES AND USES THEREOF REDPOINT BIO CORP (US) 2009-07-29 — — EP disclosed
EP-1951215-A2 HYDRAZONE DERIVATIVES AND USES THEREOF Redpoint Bio Corporation (US) 2008-08-06 — — EP disclosed
US-20070207093-A1 Hydrazone derivatives and uses thereof LINQUAGEN CORP. 2007-09-06 — — US disclosed
WO-2007056159-A2 HYDRAZONE DERIVATIVES AND USES THEREOF REDPOINT BIO CORPORATION (US) 2007-05-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070207093-A1 Hydrazone derivatives and uses thereof TAS2R1, TAS2R5, TAS1R1 MAPT 4421/4885LMNA 4648/4885POLB 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback